AR034909A1 - Derivados de aminoalquimidazol, sus preparaciones y sus aplicaciones en terapeutica - Google Patents
Derivados de aminoalquimidazol, sus preparaciones y sus aplicaciones en terapeuticaInfo
- Publication number
- AR034909A1 AR034909A1 ARP020102827A ARP020102827A AR034909A1 AR 034909 A1 AR034909 A1 AR 034909A1 AR P020102827 A ARP020102827 A AR P020102827A AR P020102827 A ARP020102827 A AR P020102827A AR 034909 A1 AR034909 A1 AR 034909A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- therapeutics
- phenyl
- aminoalquimidazol
- preparations
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000006596 (C1-C3) alkylcarbonyloxy group Chemical group 0.000 abstract 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 1
- 229940115480 Histamine H3 receptor antagonist Drugs 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000003395 histamine H3 receptor antagonist Substances 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuesto que responde a la fórmula (1) en la cual: A representa un grupo alquilo C0-6, el grupo alquilo puede estar substituido por un átomo de halógeno, un hidroxi o un fenilo; y R1, R2, R3 y R4 representan independientemente entre sí, un átomo de hidrógeno, de halógeno, un hidroxi, un grupo nitro, ciano, trifluorometilo, alquilo C1-3, fenilo, alcoxi C1-3, fenoxi, alquilcarboniloxi C1-3, benzoiloxi, -C(O)OH, alquilo-C(O)O-C1-3, fenilo-C(O)O-, -CONH2, alquilo-C(O)NH-C1-3 ó -C(O)N(alquilo C1-3)2; así como sus sales, N-óxidos e hidratos. Aplicación en terapéutica como antagonista del receptor de la histamina de tipo H3.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0110080A FR2827863A1 (fr) | 2001-07-27 | 2001-07-27 | Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR034909A1 true AR034909A1 (es) | 2004-03-24 |
Family
ID=8866000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020102827A AR034909A1 (es) | 2001-07-27 | 2002-07-26 | Derivados de aminoalquimidazol, sus preparaciones y sus aplicaciones en terapeutica |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR034909A1 (es) |
| FR (1) | FR2827863A1 (es) |
| WO (1) | WO2003011856A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022175384A1 (en) * | 2021-02-17 | 2022-08-25 | Fundación Universidad Católica De Valencia San Vicente Mártir | Small-molecule agents with antiviral activity against rna viruses |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69205287T2 (de) * | 1991-12-18 | 1996-03-14 | Schering Corp., Kenilworth, N.J. | Imidazolylalkyl- piperazin und -diazepin derivate als histamin h3 agonisten/antagonisten. |
| SG44510A1 (en) * | 1991-12-18 | 1997-12-19 | Schering Corp | Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
| AU7823894A (en) * | 1993-08-27 | 1995-03-21 | Vrije Universiteit | New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor |
| PT841922E (pt) * | 1995-05-30 | 2002-07-31 | Gliatech Inc | Derivados de ih-imidazole 4(5)-substituidos |
| WO1999024421A1 (en) * | 1997-11-07 | 1999-05-20 | Schering Corporation | Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| US6133291A (en) * | 1998-10-16 | 2000-10-17 | Schering Corporation | N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists |
-
2001
- 2001-07-27 FR FR0110080A patent/FR2827863A1/fr active Pending
-
2002
- 2002-07-26 WO PCT/FR2002/002677 patent/WO2003011856A1/fr not_active Ceased
- 2002-07-26 AR ARP020102827A patent/AR034909A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003011856A1 (fr) | 2003-02-13 |
| FR2827863A1 (fr) | 2003-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP099395A (es) | Nuevos derivados de los ácidos amino-nicotínico y amino-isonicotínico | |
| AR054087A1 (es) | Agente inhibidor de la hidratacion de esquistos y metodo de uso | |
| CR11596A (es) | Derivados de urea de tetrahidroquinoxalina, su preparacion y su aplicacion en terapeutica | |
| AR062965A1 (es) | Compuestos moduladores de receptores de glutamatometabotropicos mglur5, composiciones farmaceuticas que los contienen y usos terapeuticos en trastornos gastrointestinales, neurologicos y psiquiatricos agudos y cronicos | |
| CO5700820A2 (es) | Derivados de dioxan-2-alquilcarbamatos, su preparacion y su aplicacion en terapeutica | |
| BR112015000784A2 (pt) | grupo auxiliar assimétrico | |
| AR066583A1 (es) | Derivados de 3,3-espiroindolinona | |
| AR073136A1 (es) | Compuestos de pirrol | |
| BRPI0616799B8 (pt) | derivado de piridina e derivado de pirimidina, composições farmacêuticas, usos, inibidores de angiogênese, contra receptor de fator de crescimento de hepatócito e contra metástase de câncer, e agente antitumor | |
| NO20054856D0 (no) | 4-anilo-kinazolinderivater som antiproliferative midler | |
| AR044629A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. | |
| BR112013003228A2 (pt) | composição para controle de doença de planta e uso da mesma | |
| PE20091450A1 (es) | INHIBIDORES DE LA ESTEAROIL-CoA-DESATURASA | |
| CO6362007A2 (es) | Derivados de azaspiranil-alquilcarbamatos de heterociclos de 5 eslabones, su preparación y su aplicación en terapeútica | |
| ES2531190T3 (es) | Método para producir un compuesto de 4-oxoquinolina | |
| AR070485A1 (es) | Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica | |
| AR060812A1 (es) | Moduladores de receptores metabotropicos de glutamato mglur5, composiciones farmaceuticas que los contienen y usos en procesos patofisiologicos y trastornos que afectan el scn | |
| CO6351789A2 (es) | Derivados de carbamatos de alquiltiazoles, su preparacion y su aplicacion en terapeutica | |
| AR028649A1 (es) | Derivados de 4-(2-feniltiazol-5-il)-1,4-diazabiciclo [3.2.2]nonano, su preparacion y su aplicacion en terapéutica | |
| UY29388A1 (es) | Derivados del (1,5-difenil-h-pirazol-3-il)oxadiazol, su preparación y su aplicacion en terapéutica. | |
| AR060810A1 (es) | Moduladores de receptores metabotropicos de glutamato mglur5, composiciones farmaceuticas que los contienen y usos en procesos patofisiologicos y trastornos que afectan el scn | |
| PE20242216A1 (es) | Compuestos de heteroaril-urea novedosos como inhibidores de kv7.2 | |
| PA8607701A1 (es) | Compuestos | |
| BR0314883A (pt) | Derivados de piridoindolona substituìdos em -3 por uma fenila, seu preparo e sua aplicação em terapêutica | |
| CO6331306A2 (es) | Derivados de n-heterociclico-imidazo[1,2alfa]piridina-2-carboxamidas su preparacion y su aplicacion en terapeutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |